Biomedical applications of Pt(II) metallacycle/metallacage-based agents: From mono-chemotherapy to versatile imaging contrasts and theranostic platforms
•The importance of molecular imaging-guided Pt(II) metallacycles/metallacages chemotherapy, which can precisely provide powerful tools for monitoring and evaluating their biodistribution and therapy efficiency.•The importance of the combination of Pt(II) metallacycles/metallacages with phototherapy....
Saved in:
Published in | Coordination chemistry reviews Vol. 443; p. 214017 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Elsevier B.V
15.09.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | •The importance of molecular imaging-guided Pt(II) metallacycles/metallacages chemotherapy, which can precisely provide powerful tools for monitoring and evaluating their biodistribution and therapy efficiency.•The importance of the combination of Pt(II) metallacycles/metallacages with phototherapy. The synergistic chemo-phototherapy demonstrated advantages to address the issues of chemotherapy.•The combination of chemo-phototherapy and imaging platform can be readily built from the Pt(II) metallacycles/metallacages, which could show huge potentials in molecular imaging, materials science, and biomedicine.
Platinum-based coordination chemistry has laid the foundation for the development of numerous metal complexes and provoked their applications in cancer chemotherapy. It is noteworthy that Pt(II) metallacyles/metallacages formed through coordination-driven self-assembly exhibit improved optical properties and superior anticancer efficacies in comparison with their precursors. To this end, the employment of metallacycles/metallacages as chemotherapy agents, imaging contrasts and multifunctional theranostic platforms has attracted tremendous attention. In this context, we provide an insight into the progression of Pt(II) metallacycles/metallacages from mono-chemotherapeutic agents to versatile imaging contrasts and theranostic platforms. |
---|---|
ISSN: | 0010-8545 1873-3840 |
DOI: | 10.1016/j.ccr.2021.214017 |